[8]
By notice of motion dated March 22, 2005, Novopharm brought a motion ("Protective Order Motion") for a protective order, a schedule and an order that the application be specially managed. The Protective Order Motion was initially returnable on April 4, 2005 but was adjourned to April 11, 2005 when it was heard, in part, by Prothonotary Lafrenière. On April 11, 2005, Prothonotary Lafrenière ordered that the proceeding be specially managed and that the remainder of the Protective Order Motion be adjourned.
The Disclosure Order